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Objectives: to assess the influence of clinical and graft factors on the development of stenotic lesions. In addition the
implications of any significant correlation for duplex surveillance schedules or surgical bypass techniques was examined.
Patients and methods: in a prospective three centre study, preoperative and peroperative data on 300 infrainguinal
autologous vein grafts was analysed. All grafts were monitored by a strict duplex surveillance program and all received
an angiogram in the first postoperative year. A revision was only performed if there was evidence of a stenosis of 70%
diameter reduction or greater on the angiogram.
Results: the minimum graft diameter was the only factor correlated significantly with the development of a significant
graft stenosis (PSV-ratio [2.5) during follow-up (p=0.002). Factors that correlated with the development of event-
causing graft stenosis, associated with revision or occlusion, were minimal graft diameter (p=0.001), the use of a
venovenous anastomosis (p=0.005) and length of the graft (p=0.025). Multivariate regression analysis revealed that
the minimal graft diameter was the only independent factor that significantly correlated with an event-causing graft
stenosis (p=0.009). The stenosis-free rates for grafts with a minimal diameter <3.5 mm, between 3.5–4.5 and [4.5 mm
were 40%, 58% and 75%, respectively (p=<0.05). Composite vein and arm-vein grafts with minimal diameters[3.5 mm
were compared with grafts which consisted of a single uninterrupted greater saphenous vein with a minimal diameter of
<3.5 mm. One-year secondary patency rates in these categories were of 94% and 76%, respectively (p=0.03).
Conclusions: a minimal graft diameter <3.5 mm was the only factor that significantly correlated with the development
of a graft-stenosis. However, veins with larger diameters may still develop stenotic lesions. Composite vein and arm-vein
grafts should be used rather than uninterrupted small caliber saphenous veins.
Key Words: Infrainguinal vein graft; Vein-graft stenosis; Graft surveillance; Graft factors.
Introduction considered to be indicated for all infrainguinal vein
grafts at least for the first year.18,19 However, it would
Autologous vein has been the preferred graft material be advantageous to be able to tailor surveillance pro-
grams so that only patients with grafts at high risk offor infrainguinal arterial reconstruction since the use
of reversed saphenous vein was first described in stenosis are followed by intensive surveillance. There-
fore, factors which are associated with a high or a1949 by Kunlin.1 Unfortunately, 20–30% of vein grafts
develop stenoses in the first postoperative year, due low-risk for the development of vein-graft stenoses
need to be defined.to myointimal hyperplasia.2–6 The majority of graft
stenoses are asymptomatic until they progress to graft In this report we present the results of a prospective
cohort study of patients with infrainguinal venousocclusion.7 Regular non-invasive examination fol-
lowed by elective revision of failing but non-occluded bypasses, who were enrolled into a fixed protocol of
serial non-invasive testing for the identification ofgrafts have become a standard strategy, which is be-
lieved to salvage conduits as well as limbs.8–12 Duplex severe lesions in the graft or its adjacent arterial seg-
ments. Surgical or catheter interventions were per-ultrasound scanning, despite the fact that it is time
consuming, is currently the most commonly used formed when high-grade lesions were confirmed by
angiography.method.3,4,7,13–17 A surveillance program is generally
In this multicentre study standardised inclusion cri-
teria, uniform surveillance techniques in the par-* Please address all correspondence to: M. M. Idu, Geerpolderweg
8, 2807 LS Gouda, The Netherlands. ticipating centres and digital subtraction angiography
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(DSA) were used in all patients for validation of patient by pre- and intraoperative angiograms on the
basis of patency of the crural vessels and the conditionlesions. The objectives of this analysis were to identify
clinical and graft factors that correlated with the de- of the pedal arch, as proposed by the Ad Hoc Com-
mittee on reporting standards for lower extremityvelopment of stenotic lesions, and to investigate the
option of modifying grafting techniques or duplex- ischaemia (Rutherford run-off score).20
surveillance programs accordingly.
Bypass operation
Patients and Methods
A variety of operative techniques were used to perform
the bypass procedures. In situ saphenous vein graftingFrom June 1993 to September 1995, 346 patients were
was the preferred method if there was a suitableentered into a prospective follow-up study after infra-
ipsilateral saphenous vein available. Ectopic veinsinguinal autologous vein bypass grafting that involved
were used, either in a reversed or a non-reverseda surveillance program. Preoperative clinical data and
fashion depending on the vein taper and the optimalintraoperative details of 346 infrainguinal vein grafts
size match between vein graft, inflow and recipientwere prospectively recorded. This study was a com-
arteries. Distal small or fibrotic segments were replacedbined effort of three vascular surgical departments:
by a segment of arm vein or contralateral greaterthe University Hospital Maastricht (61 patients), Sint
saphenous vein. All operations were performed byAntonius Hospital Nieuwegein (62 patients), and Cath-
vascular surgeons, vascular fellows, or by residents inarina Hospital Eindhoven (177 patients). All centres
their last term of surgical training supervised by ahad a well-equipped and staffed vascular laboratory.
vascular surgeon. All operations were done on eitherThere was only one graft per patient included in
general or epidural anaesthesia. Peroperative graftthis study. The recorded preoperative clinical factors
factors were recorded on a standardised form filledrecorded included:
in by the operating surgeon immediately after the
1 – indication for revascularisation procedure. Postoperative anticoagulation with di-
2 – preoperative ankle–brachial blood pressure coumarol or acenocoumarol was instituted post-
index operatively in all patients who had no contra-
3 – presence of diabetes mellitus indications for its use.
4 – smoking habits
5 – hypertension
6 – angina pectoris or
7 – previous history of myocardial infarction Duplex assessment
8 – of myocardial revascularisation
9 – of central vascular reconstruction or The patients were monitored by a graft surveillance
10 – of peripheral vascular reconstructions. protocol consisting of clinical evaluation and serial
multiple non-invasive haemodynamic testing at 6The crural run-off score was graded according to
weeks, 3, 6, 9 and 12 months after operation. If thethe Suggested Standards for Reports Dealing with
graft was revised during follow-up the surveillanceLower Limb Ischemia.20 In addition, the following graft
schedule was resumed as for newly implanted grafts.characteristics were recorded:
At these visits the ankle and brachial blood pressure
1 – graft-technique were measured, and a color-flow duplex scanning of
2 – proximal anastomotic site the whole graft and adjacent arteries was performed.
3 – distal anastomotic site When surveillance examinations revealed one of the
4 – site of any venovenous anastomoses following criteria indicating an abnormality within the
5 – external diameters of the vein graft graft or adjacent arterial segments, a digital subtraction
6 – total length of the graft prior to wound closure. angiography was performed. The criteria used were:
1 – recurrent claudication or restpainIn addition, the intraoperative quality control
method was recorded, which either was angioscopy, 2 – interval decrease of ankle–brachial index >0.15
3 – PSV-ratio >2.0angiography or duplex examination. Preoperative
angiography was performed in all cases to identify the 4 – peak systolic velocity in the middle of the graft
<45 cm/secoptimal site of the proximal and the distal anastomosis.
The status of the distal run-off was assessed in each 5 – end-diastolic velocity >20 cm/sec.
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A PTA or open surgical procedure was only per- autologous vein bypass grafts of the infrainguinal
arteries that entered postoperative follow-up wereformed if the angiogram confirmed the presence of a
stenotic lesion with a [70% diameter reduction. studied. Of the 300 patients 179 (60%) were men, and
121 (40%) were women. The mean age was 70 (rangeThe duplex equipment used was: Acuson 128 XP/
10 (Catharina Hospital), Hewlett–Packard Sonos 1000 33–93). Diabetes mellitus (type 1 or 2) was present in
117 (39%) patients. Critical ischaemia was the in-(University Hospital Maastricht), and Hewlett–
Packard Sonos 2000 (Sint Antonius Hospital Nieuweg- dication for the bypass procedure in 216 (72%). Eighty-
three (28%) procedures were redo operations as aian). In all three centres a 7.5 MHz transducer was
used. All examinations were performed by qualified previous attempt of revascularisation of the popliteal
or crural arteries in the same limb had been performed.technologists. The vein graft was examined from the
groin down its entire length to the distal anastomosis The distal anastomosis was to the level of the popliteal
artery or tibioperoneal trunk in 150 (50%) and to aand into the first few cm of the recipient run-off artery.
The same surveillance protocol was used in the three crural artery in 150 (50%). Two hundred and thirty-
seven (79%) of grafts consisted of a single greaterparticipating institutions. Adherence to the protocol
was verified by a visiting data-manager and a study saphenous vein segment, while composite grafts of
multiple saphenous or arm vein segments were usednurse. To assess the occurrence of graft-stenoses, PSV-
ratios of [2.5 were used as an indicator of significant in 63 (21%). Of those, 13 (4%) had arm-vein segments
used.graft stenosis. An event-causing stenosis was defined as
a stenosis required a revision, or one causing occlusion
before revision could be undertaken. All revised le-
sions had a diameter reduction greater than 70% on
Vein-graft stenosisconfirmatory angiography.
Seventeen preoperative risk factors and graft char-
acteristics were correlated with the occurrence of two
different end points, i.e. the development of significantData analysis
graft stenosis and event-causing graft stenosis during
follow-up. The univariate correlation of all variablesThe occurrence of significant graft stenosis and event-
with the two end points during follow-up is indicatedcausing graft stenosis were the end points of patency
in Table 1. The only factor which significantly cor-and were correlated with the different factors. The
related with the development of significant graft stenosistime interval between the operation and the occurrence
was the minimum graft diameter. Factors that had aof the stenosis was recorded. Univariate comparison
significant correlation with the development of event-between the stenotic and non-stenotic grafts was per-
causing graft-stenosis were the minimum graft diameter,formed for all defined patient and bypass char-
use of venovenous anastomosis and the length of theacteristics using logrank testing. To examine
graft (Table 1). These three factors were selected for aindependent associations variables with significant
multivariate analysis with a Cox proportional hazardgroup differences at univariate comparison were com-
model21 with event-causing graft stenosis as end pointbined with some factors of particular clinical relevance
(Table 2). Some additional clinically relevant risk fac-and were subjected to a multiple regression analysis
tors were selected for this analysis as well. Theseusing a Cox proportional hazard model.21 For these
factors were:analyses SPSS 7.0 for Windows statistical software was
used. 1 – site of distal (crural) anastomosis
2 – grafting technique (non in situ technique)
3 – previous peripheral revascularisation
4 – indication for the operation (rest pain of gan-
Results grene).
Patient series The minimum graft diameter was the single in-
dependent factor that significantly correlated with the
Forty-six patients were not considered for analysis development of an event-causing graft-stenosis.
Kaplan–Meier curves indicating a free-of-stenosisbecause of death of the patient (11), irreversible graft
occlusion (17), amputation with open bypass within state (Fig. 1) were constructed for groups with a intra-
operatively measured minimum graft diameter30 days after the operation (eight), or no return for
surveillance visits (10). Three-hundred patients with <3.5 mm (group 1), between 3.5 and 4.5 mm (group 2)
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Table 2. Cox proportional hazard model relating several factors and occurrence of event-
causing vein graft stenosis.
Factor b s.e. Wald Sign.
Minimum graft diameter -0.70 0.27 6.8 0.009
Venovenous anastomosis 0.47 0.26 3.17 0.08
Length of graft 0.19 0.17 1.14 0.29
Crural anastomosis -0.05 0.26 0.03 0.85
Grafting technique -0.01 0.23 0.002 0.96
Previous peripheral reconstruction -0.11 0.25 0.20 0.65
Critical ischaemia 0.33 0.28 1.40 0.24
The factors were categorised into subgroups the same way as described in Table 2.
composite vein segments or arm veins to obtain a
wider conduit, were compared. Thus, two groups
were defined: group A consisting of 25 single segment
greater saphenous vein grafts, all with a minimum
graft diameter of <3.5 mm, and group B consisting of
11 arm vein grafts and 41 composite vein grafts, all
with a minimum diameter of [3.5 mm. Life-table
analysis demonstrated no difference in free-of-stenosis
rates with 12 month patencies of 38% and 55%, re-
spectively (p=0.1). However, the secondary patency
at 1 year was 76% and 94%, respectively (p=0.03). The
secondary patency in group B was comparable with the
patency of grafts which consisted of a single segment of
greater saphenous vein with a minimum diameter of
[3.5 mm (94% and 93%, respectively). If femorocrural
grafts only were considered, the 1-year secondary
patency in group A (20 greater saphenous femo-
rocrural grafts) and group B (24 arm or composite
femorocrural grafts) were 75%, and 91%, respectively
(N.S.).
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Group 3
Grafts at risk
0 months 6 months 12 months 18 months 24 monthsMinimal graft diam.
< 3.5 mm        (group 1) 38 16 14 10 7
3.5–4.5 mm    (group 2) 166 100 71 40 27
> 4.5 mm        (group 3) 96 76 53 36 22
Fig. 1. Rate of maintenance of free-of-stenosis state, stenosis defined Discussion
as a focal PSV-ratio [2.5, represented by Kaplan–Meier curves in
patient groups according to the intraoperatively measured minimal
A number of studies have tried to unravel the origingraft diameter: group 1 (diameter <3.5 mm), group 2 (diameter
3.5–4.5 mm) and group 3 (diameter >4.5 mm). (Group 1 vs. group of vein-graft stenoses.2–4,22 Assessing the influence of
2: p=0.02, group 1 vs. group 3: p<0.001, group 2 vs. group 3: several preoperative patient and intraoperatively de-
p=0.03).
termined graft characteristics on stenosis formation
was the subject of the present analysis. Of all factorsand[4.5 mm (group 3). At 1 year group 1, 2 and 3 had
investigated in our study, the minimum graft diameterfree-of-stenosis rates of 40%, 58% and 75%, respectively.
appeared to be the only variable that significantlyGroup 1 differed from groups 2 and 3 (p, respectively
correlated with the occurrence of graft-stenosis.0.02, and <0.001), and group 2 differed from group 3
Markers of advanced atherosclerosis, such as diabetes(p=0.03).
mellitus, the presence of critical limb ischaemia, a high
run-off score, and the presence of tissue necrosis did
not correlate with a higher rate of vein-graft stenosis.
In addition, operative technical factors, such as theGrafting techniques
site of the distal anastomosis (crural arteries) and the
graft-technique (i.e. non in situ technique), failed toTo investigate the role of grafting technique the results
of grafts with a minimum diameter of <3.5 mm meas- show any significant correlation with the occurrence
of vein graft stenosis. Although the minimum graftured intraoperatively, and the results of grafts using
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diameter is an important risk factor for the de- femorocrural grafts with secondary patency rates were
between 5% and 55%.35–38 In contrast the 1-year sec-velopment of vein-graft stenosis, it is difficult to stratify
ondary patency rate of femorocrural grafts with com-patients into a high-risk group in which surveillance
posite vein and arm-vein grafts in our series wasis indicated and a low-risk group that does not require
91%. These results are in concordance with those ofit, as patients with a graft diameter between 3.5 to
Harward et al., and of Chalmers et al., who reported4.5 mm and >4.5 mm still have a significant restenosis
1-year secondary patencies of 85–91%.39,40 In con-rate.
clusion, the use of arm-vein or composite vein grafts forOur findings are in agreement with other studies,
femorocrural bypass grafting is the preferred option ifwhich also have documented an unfavourable effect
the saphenous vein is less than 3.5 mm in diameter.on durable patency of small calibre grafts.23–25 Grafts
with segments with a less than 3.5 mm diameter are
at increased risk of failure for several reasons. It has
been suggested that small calibre vein grafts are more
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